Incidence of Epstein-Barr Virus Among Women With Breast Cancer Using Monoclonal Antibodies for Latent Membrane Protein 1 (LMP1)

In Vivo. 2022 May-Jun;36(3):1513-1518. doi: 10.21873/invivo.12860.

Abstract

Background/aim: Breast cancer is a common type of cancer in Sudan. Numerous studies propose viral oncogenesis as an etiological factor for breast cancer. The aim of the study was to analyze the presence of the Epstein-Barr virus (EBV) using monoclonal antibodies against latent membrane protein 1 (LAMP1) and determine the correlation between the presence of EBV and clinicopathological characteristics.

Patients and methods: This study used immunohistochemistry to analyze the presence of EBV in 202 samples from Sudanese women diagnosed with breast cancer. Clinicopathological data were collected from patient records from the Radiation and Isotopes Centre in Khartoum State, Republic of Sudan.

Results: This study included 202 patients 168 (83.2%), 16 (7.9%), and 18 (8.9%), diagnosed with invasive ductal carcinoma, invasive lobular carcinoma, and papillary carcinoma, respectively. Axillary lymph node metastasis was present in 57 (28.2%) of cases, while 11 patients (5.4%) tested positive for EBV. The mean age of patients was 48.14±14.4 years. EBV infection was more frequently detected in invasive ductal carcinoma cases, and EBV positivity was not associated with cancer type, grade, progesterone levels, and HER2 expression. On the other hand, a statistically significant association was found between EBV presence and lymph node involvement, estrogen receptor status, and age group.

Conclusion: EBV may not play a vital role in the pathogenesis of breast carcinoma in Sudanese women.

Keywords: Epstein-Barr virus; Sudanese women; breast cancer.

MeSH terms

  • Adult
  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological*
  • Breast Neoplasms* / epidemiology
  • Breast Neoplasms* / pathology
  • Carcinoma, Ductal* / complications
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / epidemiology
  • Epstein-Barr Virus Infections* / pathology
  • Female
  • Herpesvirus 4, Human
  • Humans
  • Incidence
  • Male
  • Membrane Proteins
  • Middle Aged
  • Viral Proteins

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological
  • Membrane Proteins
  • Viral Proteins